Skip to content
Back to ANRO

Alto Neuroscience, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
3
Purchases
0
Sales
3
Purchase value
$0.00
Sale value
$3.57M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Nicholas Conrad SmithPRESIDENT AND CFO
4
Filed Oct 1, 2026Period of report Sep 29, 20260002009130-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 30, 2026
Common StockF123,170$25.7786$597.29K24,946Direct
SaleSep 30, 2026
Common StockF1886$26.87$23.81K24,060Direct
SaleSep 29, 2026
Common StockF1F2110,830$26.5826$2.95M24,060Direct
Filing footnotes · 4
  1. F1This transaction was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2026.
  2. F2This price is a weighted average price. These securities were sold in multiple transactions at prices ranging from $26.5513 to $26.5902 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  3. F3One-third (1/3rd) of the shares underlying the option vested upon the completion of the Issuer's initial public offering and two-thirds (2/3) of the shares underlying the option vested or shall vest over a period of four years. 25% of the shares underlying the time-based portion vested on December 20, 2024, and 1/48 of the shares underlying the time-based portion vested or shall vest on a monthly basis thereafter, subject to the Reporting Person's continuous service through such vesting date.
  4. F425% of the shares underlying the option vested on March 1, 2025, and one forty-eighth (1/48th) of the shares underlying the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.